Nitrite analysis in pharmaceuticals: monitoring a precursor

Nitrosamines are carcinogenic, even at trace levels. As a result, the FDA has issued guidance regarding monitoring nitrosamine impurities in drugs for human consumption [1].

Related Keywords

, General Chapter , Preconcentration Technique , Matrix Elimination , Application Notes , Pharmaceuticals , Hromatography , Drugs , Son , Ion Chromatography , Sample Preparation ,